In the United States, hemp is often confused with marijuana. It’s a consumer misconception that has, for decades, slowed the market potential for hemp in the food, dietary supplement, textile, and even lumber industries. The dietary supplement industry, in particular, has a lot to gain from hemp, and not just with hemp oil and hemp protein. A substance called cannabidiol (CBD) has shown nutritional potential for years, yet the taboo around Cannabis has kept CBD off the radar. Now, with hemp gaining a better reputation, it looks as though its little compound is finally poised for big market growth. And much of that growth could be in stress and anxiety formulas.

What Is CBD?

CBD is a phytocannabinoid that is found in industrial hemp and marijuana, which are two different varieties of the Cannabis sativa plant. The current market for CBD as a dietary supplement is based on industrial hemp, not marijuana, because marijuana also contains significant amounts of tetrahydrocannabinol (THC), a phytocannabinoid that is psychoactive and, thus, capable of making a person high. Industrial hemp contains only negligible amounts of THC—no more than, say, poppy seeds contain opiates—and so it will not get you high. The plant is, thus, safe for human consumption and useful for components including CBD.

While CBD is not psychoactive like THC, it can still have a profound influence on the human brain, but first—is CBD legal?

Legal Status of CBD

In order to understand if CBD is legal for sale and consumption, one must look at the legality of hemp oil, which can be tailor-made for high concentrations of CBD.

 

There’s more! See the rest of our writeup about studies on hemp extracts here.
(Including scientific studies on CBD, schizophrenia and overall market outlook for hemp and CBD.) 

4 Responses to What Studies Say about Hemp Extracts
  1. Thank you for clarifying a murky subject. The Nov. 2015 issue of New Republic contains a lengthy article that’s critical (and confusing) about CBD / hemp oil, entitled “the Wonder Drug.” Here in Wyoming, the legislature approved CBD oi prescriptions for epilepsy in children but refused to enact a law for cultivating hemp. Wyoming NORML is trying to pt the issue to voters in 016, but is having trouble generating the signatures required for the petition to the Sec. of State.

    I write a weekly column that’s published in the two major WYO newspapers. Is it possible to interview someone from your company?

  2. P.S. Where did the above article come from? If possible, I’d like to post it on my Hemp Diaries Facebook.


[top]

Leave a Reply

Your email address will not be published. Required fields are marked *